Rob J Van Geest, Ingeborg Klaassen, Ilse M C Vogels, Cornelis J F Van Noorden, Reinier O Schlingemann
Index: Invest. Ophthalmol. Vis. Sci. 51(4) , 1857-65, (2010)
Full Text: HTML
Purpose. An early hallmark of preclinical diabetic retinopathy is thickening of the capillary basal lamina (BL). TGF-beta, a multipotent cytokine acting through its receptors ALK5 and -1, has been postulated to be involved in this phenomenon. In light of this possible role, TGF-beta signaling and its downstream molecular effects were characterized in cultured vascular endothelial cells and pericytes of the retina. Methods. Bovine retinal endothelial cells and pericytes were stimulated with TGF-beta1 in the presence or absence of SD-208, a specific inhibitor of the TGF-beta type I receptor ALK5, or ALK5 small interfering (si)RNA. TGF-beta-signaling pathways were characterized by analysis of phosphorylated Smad2 or -1/5/8 proteins and TGF-beta target genes (PAI-1, fibronectin, CTGF, Smad7, and Id1) and protein (fibronectin). Results. ALK5 was expressed in both cell types, whereas ALK1 was exclusively expressed in endothelial cells. In endothelial cells, TGF-beta induced Smad2 phosphorylation at high concentrations, which was efficiently blocked by ALK5 inhibition. In contrast, in pericytes, Smad2 phosphorylation was rapidly induced at low concentrations of TGF-beta. The ALK1-Smad1/5/8 pathway was activated by TGF-beta in endothelial cells only. TGF-beta caused ALK5-mediated upregulation of PAI-1, Smad7, and fibronectin and in pericytes at lower TGF-beta concentrations than in endothelial cells. CTGF mRNA expression was induced only in pericytes. Fibronectin protein was confirmed to be regulated by TGF-beta in both cell types. Conclusions. TGF-beta signaling in retinal endothelial cells and pericytes show that these cells, and in particular the pericytes, have the essential characteristics to allow for a role of TGF-beta in BL thickening in preclinical diabetic retinopathy.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
SD-208
CAS:627536-09-8 |
C17H10ClFN6 |
Inhibition of Transforming Growth Factor-β (TGF-β) Signaling...
2015-08-01 [J. Cell. Biochem. 116 , 1797-805, (2015)] |
SD-208, a novel transforming growth factor beta receptor I k...
2004-11-01 [Cancer Res. 64 , 7954-7961 , (2004)] |
Progesterone inhibits endometrial cancer invasiveness by inh...
2014-10-01 [Cancer Prev. Res. (Phila.) 7(10) , 1045-55, (2014)] |
Differential regulation of TGF-β-induced, ALK-5-mediated VEG...
2015-02-01 [Neuro. Oncol. 17(2) , 254-65, (2015)] |
Overexpression of smad7 blocks primary tumor growth and lung...
2014-10-01 [Clin. Cancer Res. 20(19) , 5097-112, (2014)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved